Pilar Retamar Gentil

Profesora Asociada CIS
pretamar@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin Grupo
Tipo Año Título Fuente
Artículo2021 Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study LANCET INFECTIOUS DISEASES
Corrección2020 Author Correction: A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance (Nature Microbiology, (2019), 4, 7, (1160-1172), 10.1038/s41564-019-0410-0) NATURE MICROBIOLOGY
Artículo2020 Catheter-related bloodstream infections: predictive factors for Gram-negative bacteria aetiology and 30 day mortality in a multicentre prospective cohort JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum β-lactamase-producing Escherichia coli in the community: an interrupted time-series analysis LANCET INFECTIOUS DISEASES
Artículo2020 Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project BMJ OPEN
Artículo2019 A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance NATURE MICROBIOLOGY
Artículo2019 Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study CLINICAL INFECTIOUS DISEASES
Artículo2019 Opportunities for antibiotic optimisation and outcome improvement in patients with negative blood cultures: Study protocol for a cluster-randomised crossover trial, the NO-BACT study BMJ OPEN
Artículo2019 Predictive value of the kinetics of procalcitonin and C-reactive protein for early clinical stability in patients with bloodstream infections due to Gram-negative bacteria DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Editorial2019 Un paso adelante en la definición de indicadores PROA: medir bien para trabajar mejor FARMACIA HOSPITALARIA
Artículo2018 A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients CLINICAL MICROBIOLOGY AND INFECTION
Artículo2018 Management of bloodstream infections by infection specialists: an international ESCMID cross-sectional survey INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Artículo2017 Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferiority clinical trial BMJ OPEN
Revisión2016 Escherichia coli: an old friend with new tidings FEMS MICROBIOLOGY REVIEWS
Artículo2015 Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2015 Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2015 Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia? JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2014 Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Artículo2013 Evaluating the quality of antimicrobial prescribing: Is standardisation possible? ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Artículo2013 Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-beta-Lactamase-Producing Escherichia coli ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013 Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study BMC INFECTIOUS DISEASES
Artículo2012 Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based Analysis ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts CLINICAL INFECTIOUS DISEASES
Revisión2010 Current management of bloodstream infections EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
Artículo2010 Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals CLINICAL MICROBIOLOGY AND INFECTION
Artículo2010 Headache and blurred vision in a 26 years old woman MEDICINA CLINICA

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2012 31/12/2014 Investigador/a Interacción de mecanismos plasmídicos y cromosómicos de resistencia a quinolonas en escherichia coli y su efecto en la resistencia, fitness, toxicidad celular y expresión en biocapas (PI11/00934) Ministerio de Ciencia e Innovación (Instituto de Carlos III) (Nacional)